'Don't just get stuck in one therapy area,' Deloitte warns pharmaceutical industry

featured-image

Colin Terry, life sciences partner at Deloitte, weighs in on investment flows in the global pharmaceutical market and the recent focus on GLP-1 weight loss drugs.

Colin Terry, life sciences partner at Deloitte, weighs in on investment flows in the global pharmaceutical market and the recent focus on GLP-1 weight loss drugs..